Drug - Humegon
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Menotropins (fsh;lh)
Multiple ingredients are in alphabetical order.

Strength - 75 IU/VIAL;75 IU/VIAL
The potency of the active ingredient(s), Menotropins (fsh;lh). May repeat for multiple part products.

The firm name holding legal responsibility for Humegon. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020328
The FDA assigned number to Humegon. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Humegon. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 1, 1994
The date Humegon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Humegon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Humegon is in. Format is RX, OTC, DISCN.

Applicant Full Name - Organon Usa Inc
The full name of the firm holding legal responsibility for the new application of Humegon.